Clinical Trial Update: Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial results for abiraterone acetate in asymptomatic or mildly symptomatic metastatic castration-resistant prostate cancer are posted. The study evalua…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-04-09